Trial Profile
The role of tegaserod therapy in the management of dyspeptic symptoms in female patients on proton pump inhibitors for the treatment of heartburn
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2006
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary)
- Indications Heartburn; Non-ulcer dyspepsia
- Focus Therapeutic Use
- 03 Oct 2006 Status change
- 06 Nov 2005 New trial record.